You are here: All Products  > CorreGene Closes $14 Million Pre-A+ round for Novel TCR Drugs

CorreGene Closes $14 Million Pre-A+ round for Novel TCR Drugs

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products